title: Graves' disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha.
authors.forename: Antoine W T
authors.initials: AW
authors.lastname: van Lieshout
authors.forename: Marjonne C W
authors.initials: MC
authors.lastname: Creemers
authors.forename: Timothy R D J
authors.initials: TR
authors.lastname: Radstake
authors.forename: Lammy D
authors.initials: LD
authors.lastname: Elving
authors.forename: Piet L C M
authors.initials: PL
authors.lastname: van Riel
mesh_terms: D000068879:Adalimumab; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006111:Graves Disease / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab